Today's pharmaceutical sector has a strong trend: nearly 10 stocks have daily limit, and one pharmaceutical company has three consecutive boards

[Pharmaceutical Network Pharmaceutical Stock Market] On January 10, 2022, the pharmaceutical sector had a strong intraday trend, including Yabao Pharmaceutical, Zhongsheng Pharmaceutical, Asia Pacific Pharmaceutical, Xintian Pharmaceutical, Shapuaisi, Huashen Technology, Guizhou San Nearly 10 stocks, including Lili, Sialon Pharmaceutical, and Teyi Pharmaceutical, were trading at their daily limit
.

Among them, Asia Pacific Pharmaceuticals has closed 3 daily limit.
As of 09:30 today, the stock reported 6.
36 yuan, the turnover rate was 9.
64%, the trading volume was 48.
7282 million shares, the transaction value was 296 million yuan, and the daily limit was 104 million yuan.
During the continuous daily limit, the stock rose 33.
33% cumulatively, and the cumulative turnover rate was 18.
43%
.

The total market value of the new A shares reached 3.
413 billion yuan, and the circulating market value of A shares was 3.
216 billion yuan
.

The stock is a hot stock of innovative drugs, medicine and other concepts.
On the day, the concept of innovative drugs rose 2.
04%, and the concept of medicine rose 1.
88%
.

 　　Yabao Pharmaceuticals closed at 11.
06 yuan today
.

The stock's daily limit was at 11:13, and the daily limit was not opened.
As of the closing closing, the capital was 11.
6019 million yuan, accounting for 0.
14% of its circulating market value
.

It is reported that the stock is a hot stock in traditional Chinese medicine, innovative medicine, and optimized fertility (three children) concept.
On the same day, the concept of traditional Chinese medicine rose 2.
12%, the concept of innovative medicine rose 2.
04%, and the concept of optimized fertility (three children) rose 2.
03%
.

 　　At 10:29 today, Zhongsheng Pharmaceutical closed the daily limit
.

The current price is 12.
5, up 10.
04%
.

The main reasons for the change of the stock are: 1.
The company's main business is drug research and development, production and sales.
The main products are compound Xueshuantong series products, Zhongsheng pill series products, cefixime dispersible tablets, cefradine capsules, and sucralfate oral suspension.
liquid
.

2.
The company's wholly-owned subsidiary is developing NMN (β-nicotinamide mononucleotide), which is currently in the pilot stage
.

 　　Xintian Pharmaceutical closed at the daily limit today, with a closing price of 24.
4 yuan
.

The stock’s daily limit was set at 9:32, and the daily limit was opened 11 times.
As of the closing closing, the fund was 46.
6804 million yuan, accounting for 1.
23% of its circulating market value
.

The stock is a hot stock of traditional Chinese medicine and medical concept.
On the same day, the concept of traditional Chinese medicine rose 2.
12%, and the concept of medicine rose 1.
88%
.

 　　Sharp Aisi closed at the daily limit today, with a closing price of 10.
01 yuan
.

The stock’s daily limit was set at 9:37, and the daily limit was not opened.
As of the closing closing, the fund was 38.
7195 million yuan, accounting for 1.
2% of its circulating market value
.

The stock is a hot stock in ophthalmology, medicine, and private hospital concepts.
On the day, the concept of ophthalmology rose 2.
12%, the concept of medicine rose 1.
88%, and the concept of private hospitals rose 1.
39%
.

 　　Huashen Technology closed at the daily limit today, with a closing price of 6.
49 yuan
.

The stock's daily limit was at 10:41, and the daily limit was not opened.
As of the closing closing, the fund was 41.
689 million yuan, accounting for 1.
04% of its circulating market value
.

The stock is a hot stock in traditional Chinese medicine, innovative medicine and medical concept.
On the day, the concept of traditional Chinese medicine rose 2.
12%, the concept of innovative medicine rose 2.
04%, and the concept of medicine rose 1.
88%
.

 　　Guizhou Sanli opened at 16.
31 yuan today.
As of 11:25, the stock rose 9.
99% to 17.
83 yuan, closing the price limit
.

The stock is a traditional Chinese medicine, optimizing fertility (three children), a hot stock in the concept of medicine, the concept of traditional Chinese medicine rose 2.
12% on the day, the concept of optimizing fertility (three children) rose 2.
03%, and the concept of medicine rose 1.
88%
.

 　　Sialon Pharmaceutical closed at the daily limit today, with a closing price of 11.
23 yuan
.

The stock's daily limit was at 9:32, and the daily limit was not opened.
As of the closing closing, the fund was 39.
4343 million yuan, accounting for 3.
48% of its circulating market value
.

The stock is a hot stock in the concept of medicine, and the concept of medicine rose 1.
88% on the day
.

 　　At 11:15 today, Teyi Pharmaceutical had an intraday daily limit of 17.
53 yuan, and currently has 139,657 orders, equivalent to 245 million yuan
.

Up to now, the transaction has reached 305 million yuan, and the turnover rate is 14.
26%
.

 　　In response to the intraday strength of pharmaceutical stocks, analysts pointed out that from the news point of view, recently, CDE (the Center for Drug Evaluation of the State Drug Administration) has issued 16 guiding principles one after another
.

The 16 guiding principles cover new traditional Chinese medicines, rare disease drugs, chronic hepatitis C antiviral drugs, ulcerative colitis treatment drugs, Crohn's disease treatment drugs, antitumor drugs, etc.
, aiming to further standardize and guide the clinical practice of innovative drugs Test and provide technical specifications for reference
.